European Journal of Clinical Pharmacology

, Volume 15, Issue 3, pp 153–157 | Cite as

Oral absorption of cimetidine and its clearance in patients with renal failure

  • R. Larsson
  • G. Bodemar
  • B. Norlander


The plasma concentration curve after a single oral dose of cimetidine 200 mg was followed in 27 patients with varying degrees of chronic renal failure (creatinine clearance 1–52 ml/min) and in 46 patients with normal serum creatinine. Compared to the latter patients, the plasma concentration was higher and the elimination rate was slower in all uraemic subjects, including a group with moderate renal impairment. The preliminary recommendations of dosage for patients with a creatinine clearance below 5 ml/min, and for patients on regular haemodialysis, is cimetidine 200 mg every 12 h, 5–15 ml/min 200 mg every 12 to 8 h, 15–30 ml/min 200 mg every 8 h and 30–52 ml/min 200 mg every 6 h.

Key words

cimetidine renal failure elimination half life pharmacokinetics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shepherd, A. M. N., Stewart, W. K., Wormsley, K. G.: Peptic ulceration in chronic renal failure. Lancet1973/I, 1357–1359Google Scholar
  2. 2.
    Doherty, C. C., O'Connor, F. A., Buchanan, K. D., Sloan, J. M., Ardill, J. E. S., McGeown, M. G.: Peptic ulcer in renal failure. Abstract, British Society of Gastroenterology (1977)Google Scholar
  3. 3.
    Hadjiannakis, E. J., Evans, D. E., Smellie, W. A. B., Calne, R. Y.: Gastrointestinal complications after renal transplantation. Lancet1971/II, 781–785Google Scholar
  4. 4.
    Spanos, P. K., Simmons, R. L., Rattazzi, L. C., Kjellstrand, C. M., Buselmeier, T. J., Najarian, J. S.: Peptic ulcer disease in the transplant recipient. Arch. Surg.109, 193–197 (1974)Google Scholar
  5. 5.
    Ventkateswaran, P. S., Jeffers, A., Hocken, A. G.: Gastric acid secretion in chronic renal failure. Br. med. J.1972/IV, 22–23Google Scholar
  6. 6.
    Canavan, J. S. F., Briggs, J. D., Bell, P. R. F.: Gastric acid secretion following renal transplantation. Br. J. Surg.62, 737–740 (1975)Google Scholar
  7. 7.
    Bodemar, G., Walan, A.: Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet1978/I, 403–407Google Scholar
  8. 8.
    Blackwood, W. S., Maudgal, D. P., Pickard, R. G., Lawrence, D., Northfield, T. C.: Cimetidine in duodenal ulcer. Controlled trial. Lancet1976/II, 174–176Google Scholar
  9. 9.
    Jones, R. H., Rudge, C. J., Bewick, M., Parsons, V., Weston, M. J.: Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation. Br. med. J.1978/I, 398–400Google Scholar
  10. 10.
    Canavan, J. S. F., Briggs, J. D.: Cimetidine clearance in renal failure. Cimetidine. Burland, W. L. and M. A. Simkins (eds.), pp. 75–80. Amsterdam: Excerpta Medica 1977Google Scholar
  11. 11.
    Ma, K. W., Brown, D. C., Master, D. S., Silvis, S. E.: Effects of renal failure on blood levels of cimetidine. Gastroenterology74, No. 2, 473–477 (1978)Google Scholar
  12. 12.
    McMillen, M. A., Ambis, D., Siegel, J. H.: Cimetidine and mental confusion. New Engl. J. Med.298, 284–285 (1978)Google Scholar
  13. 13.
    Delaney, J. C., Revey, M.: Cimetidine and mental confusion. Lancet1977/II, 512Google Scholar
  14. 14.
    Grave, W., Nadorp, J. H. S. M., Rutten, J. J. M. H.: Cimetidine and renal failure. Lancet1977/II, 719–720Google Scholar
  15. 15.
    Randolph, W. C., Osborne, V. L., Walkenstein, S. S., Intoccia, A. P.: High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. J. Pharm. Sci.66, 1148–1150 (1977)Google Scholar
  16. 16.
    Bodemar, G., Walan, A., Norlander, B.: Blood concentration of cimetidine during long-term treatment. Amsterdam: Excerpta Medica 1978Google Scholar
  17. 17.
    Burland, W. L., Duncan, W. A. M., Hesselbo, T., Mills, J. G., Sharpe, P. C., Haggie, S. J., Wyllie, J. H.: Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br. J. clin. Pharmacol.2, 481–486 (1975)Google Scholar
  18. 18.
    Gibaldi, M., Perrier, D.: Drug distribution and renal failure. J. clin. Pharmacol.12, 201–204 (1972)Google Scholar
  19. 19.
    Reuning, R. H., Sams, R. A., Notari, R. E.: Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. J. clin. Pharmacol.13, 127–141 (1973)Google Scholar
  20. 20.
    Pounder, R. E., Williams, J. G., Hunt, R. H., Vincent, S. H., Milton-Thompson, G. J., Misiewics, J. J.: The effects of oral cimetidine on food-stimulated gastric aced secretion and 24-hour intragastric acidity. Cimetidine, Burland, W. L. and M. A. Simkins (eds.), pp. 189–204. Amsterdam: Excerpta Medica 1977Google Scholar
  21. 21.
    Bodemar, G., Norlander, B., Walan, A.: Cimetidine in the treatment of activ peptic ulcer disease. Cimetidine. Burland, W. L. and M. A. Simkins (eds.), pp. 224–239. Amsterdam: Excerpta Medica 1977Google Scholar
  22. 22.
    Norlander, B.: Personal communication (1978)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • R. Larsson
    • 1
  • G. Bodemar
    • 1
  • B. Norlander
    • 1
  1. 1.Departments of Nephrology and Clinical PharmacologyUniversity HospitalLinköpingSweden

Personalised recommendations